Results 11 to 20 of about 8,176 (221)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

open access: goldPatient Preference and Adherence, 2017
Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of ...
Anderson MS   +4 more
doaj   +3 more sources

Is brimonidine ophthalmic a safe therapy for infants?

open access: goldJournal of Clinical Pharmacy and Therapeutics, 2006
Brimonidine is a topical alpha-2 agonist commonly used in the treatment of glaucoma. Brimonidine toxicity resembles that of clonidine overdose and is probably due to both imidazoline and alpha-2 adrenergic receptor effects. We report a case of a 6-week-old infant with congenital glaucoma who developed bradycardia and hypotension following the ...
G. Patrick Daubert
openalex   +4 more sources

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops [PDF]

open access: greenGMS Ophthalmology Cases, 2020
Objective: We report three cases of preterm neonates who presented with central nervous system (CNS) and respiratory depression after inadvertent exposure to brimonidine tartrate 0.2% and timolol maleate 0.5% fixed-combination ophthalmic drops.Case ...
Azarcon, Corrina P., Santiago, Darby E.
doaj   +2 more sources

Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons [PDF]

open access: yesMolecular Neurodegeneration, 2011
Background Brimonidine is a common drug for lowering ocular pressure and may directly protect retinal ganglion cells in glaucoma. The disease involves early loss of retinal ganglion cell transport to brain targets followed by axonal and somatic ...
Crish Samuel D   +4 more
doaj   +5 more sources

The potential of brimonidine for myopia treatment: Targeting MMP-2 to regulate choroidal thickness and control eye growth [PDF]

open access: yesHeliyon
Drug treatment studies are a focal point for identifying novel approaches to reduce myopia progression through basic science research. Here, we investigated the effects of various brimonidine administration routes and concentrations on form-deprivation ...
Aiqun Xiang   +8 more
doaj   +2 more sources

Effect of a fixed combination of ripasudil and brimonidine on aqueous humor dynamics in mice [PDF]

open access: yesScientific Reports
Ripasudil–brimonidine fixed-dose combination (K-232) simultaneously targets three different intraocular pressure (IOP) lowering mechanisms, increasing trabecular meshwork outflow and uveoscleral outflow, and reducing aqueous humor production Vascularly ...
Reiko Yamagishi-Kimura   +2 more
doaj   +2 more sources

The role of brimonidine tartrate gel in the treatment of rosacea

open access: greenClinical, Cosmetic and Investigational Dermatology, 2015
Rosacea is a chronic cutaneous condition with a prevalence rate ranging from 9.6% to 22% in recent studies. Facial erythema (transient and permanent) is considered a common denominator that is frequently observed in all subtypes of rosacea and is estimated to affect more than 40 million people worldwide.
Jackson JM   +4 more
openalex   +5 more sources

Brimonidine Eye Drops within the Reach of Children: A Possible Foe [PDF]

open access: yesChildren
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta   +5 more
doaj   +2 more sources

Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil

open access: yesClinical Ophthalmology
Kenji Inoue,1 Minako Shiokawa,1 Shiho Kunimatsu-Sanuki,2 Goji Tomita,1,3 Kyoko Ishida3 1Inouye Eye Hospital, Tokyo, Japan; 2Nishikasai Inouye Eye Hospital, Tokyo, Japan; 3Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo ...
Inoue K   +4 more
doaj   +3 more sources

Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension

open access: yesОфтальмохирургия, 2021
Purpose. To present data on the mechanism of action, efficacy, and side effects of various brimonidine dosage forms in the treatment of glaucoma and ocular hypertension.Material and methods. To perform the review, literature sources were searched through
A. V. Sidorova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy